*  Exposure Controls/Personal Protection  *
Respiratory Protection:NOT EXPECTED TO REQUIRE PERSONAL RESPIRATOR
    USAGE. NIOSH/MSHA APPROVED RESPIRATOR APPROPRIATE FOR EXPOSURE OF
    CONCERN .
Ventilation:PROPERLY SEALED CONTAINERS ARE NOT EXPECTED TO REQUIRE ANY
    SPECIAL VENTILATION.
Other Protective Equipment:LABCOAT. HANDLING DEVICES (SYRINGE SHIELDS &
    TONGS).
Work Hygienic Practices:NO SMOKING, EATING OR DRINKING SHOULD BE
    ALLOWED IN ANY AREA WHERE RADIOACTIVE MATERIALS ARE HANDLED OR
    STORED.
Supplemental Safety and Health
APPEAR/ODOR:CAP VIAL; ODORLESS. EFTS OF OVEREXP:RADIA EXPOS (CANCER,
    LEUKEMIA, GENETIC & TERATOGENIC EFTS) ARE BELIEVED TO INVOLVE
    LEVELS OF RADIA EXPOS WHICH ARE HIGHER THAN THOSE PERMITTED OCCUP.
    FI RST AID PROC:RADIA SFTY PERS. EYES:IF ASPLASH OCCURS, WASH
*  Product Identification  *
*  Composition/Information on Ingredients  *
    CONTAMINATION FROM SKIN, EYES OR CLTHG. READ PACKAGE INSERT PRIOR
    TO USE.
Ingred Name:SUPP DATA:RADIOACTIVITY CAN BE REMOVED. NOTIFY RADIATION
    SAFETY PERSONNEL.
Ingred Name:ISOJEX SYRINGES (CONTAINING INGREDS 2-8)
Fraction by Wt: <0.1%
OSHA PEL:0.1 PPM, C
ACGIH TLV:0.1 PPM, C
Ingred Name:SODIUM CHLORIDE
Fraction by Wt: 0.9%
Ingred Name:SODIUM MONOHYDROGEN PHOSPHATE (2:1:1); (SODIUM PHOSPHATE,
    DIBASIC)  (SARA III)
Fraction by Wt: <0.1%
Ingred Name:POTASSIUM PHOSPHATE, MONOBASIC
Fraction by Wt: <0.1%
Ingred Name:GUANIDINE, MONOHYDROCHLORIDE; (GUANIDINE HYDROCHLORIDE)
Ingred Name:BENZYL ALCOHOL
Fraction by Wt: 0.9%
Ingred Name:WATER
    IODINE)
Fraction by Wt: <1%
OSHA PEL:0.1 PPM, C
ACGIH TLV:0.1 PPM, C
Ingred Name:SODIUM HYDROXIDE  (SARA III)
OSHA PEL:2 MG/M3
Ingred Name:SODIUM SULFITE (2:1); (SODIUM SULFITE)
Ingred Name:POTASSIUM IODIDE
Ingred Name:WATER
Ingred Name:SPILL PROC:RADIOACTIVE WASTE SHOULD BE DISPOSED OF
    ACCORDING TO STD OPERATING PROC ESTABLISHED BY RADIA SFTY OFFICER.
Ingred Name:OTHER PREC:APPROP TO GOVT AGENCY AUTH TO LICENSE USE OF
*  Hazards Identification  *
Routes of Entry: Inhalation:YES  Skin:NO  Ingestion:YES
Reports of Carcinogenicity:NTP:NO    IARC:NOOSHA:NO
Health Hazards Acute and Chronic:THE HAZ, NON-RADIOACTIVE INGREDS FOUND
    IN PROD ARE SKIN/EYE IRRITS, BUT DUE TO SMALL QTYS PRESENT IN EACH
    CONTR, NO ADVERSE EFTS ARE EXPECTED TO OCCUR FROM THESE COMPONENTS.
    INHAL:A VERY SMALL FRACTIO N OF PROD COULD BREAK DOWN & EMIT
    RADIOACTIVE FUMES CONTAINING PROD. NOT EXPECTED TO BE A HLTH HAZ.
    (EFTS OF OVEREXP)
Explanation of Carcinogenicity:NOT RELEVANT.
Effects of Overexposure:HLTH HAZ:INGEST:MAY CAUSE ASYMPTOMATIC
    BY THYROID CAN RSLT IN SLIGHT TO TOTAL THYROID DYSFUNCTION.
    SKIN:NOT EXPECTED TO PRDCE ACUTE AD VERSE HLTH EFTS. EYES:NO
    ADVERSE EFTS EXPECTED, BUT MAY CAUSE MECH IRRIT. CHRONIC:HTLH RISK
    ASSOC W/CHRONIC (SUPP DATA)
Medical Cond Aggravated by Exposure:NO INFORMATION FOUND.
*  First Aid Measures  *
First Aid:INHAL:REMOVE TO FRESH AIR. SUPPORT BRTHG (GIVE O2/ARTF RESP)
    . INGEST:NOTIFY RADIA SFTY PERS IMMED. THE AMT OF PROD IN THYROID
    GLAND SHOULD BE ASSESSED/DOCUMENTED. A THYROID BLOCKING AGENT MAY B
    E WARRANTED & ADMINISTERED UNDER DIRECTION OF MD. SKIN:WASH
    AFFECTED AREA THORO W/SOAP & WATER UNTIL NO MORE RADIOACTIVITY CAN
    BE REMOVED. ALWAYS BLOT DRY. DO NOT ABRADE SKIN. NOTIFY (SUPP DATA)
*  Fire Fighting Measures  *
Extinguishing Media:USE ANY MEANS SUITABLE FOR EXTINGUISHING
    SURROUNDING FIRE.
Fire Fighting Procedures:WEAR NIOSH/MSHA APPROVED SCBA & FULL
    PROTECTIVE EQUIPMENT .
Unusual Fire/Explosion Hazard:NOT CONSIDERED TO BE A FIRE OR EXPLOSION
    HAZARD.
*  Accidental Release Measures  *
Spill Release Procedures:IF PROD IS RECEIVED IN LEAKING CNDTN OR ANY
    LOSS/RELS OF RADIOACTIVE CONTENTS OCCURS, NOTIFY YOUR RADIA SFTY
    DEPT & MALLINCKRODT. ALL CLEANUP OPERATIONS SHOULD BE PERFORMED
    ACCORDING TO STANDARD OPERA TING PROC ESTABLISHED FOR YOUR
Neutralizing Agent:NONE SPECIFIED BY MANUFACTURER.
*Handling and Storage  *
Handling and Storage Precautions:STORE AT 2C TO 8C. HNDLG TIME SHOULD
    BE KEPT TO A MIN & APPROP SHIELDING SHOULD BE USED. HNDLG DEVICES
    SUCH AS SYRINGE SHIELD & TONGS SHOULD BE USED.
Other Precautions:STOR/DISP OF PROD SHOULD BE CONTROLLED IN A MANNER
    WHICH IS IN COMPLIANCE W/APPROP REGS OF FED/STATE GOVT AGENCY AUTH
    TO LICENSE USE OF THIS RADIONUCLIDE. RADIOACTIVE DRUGS MUST BE
*  Physical/Chemical Properties  *
HCC:A2
Solubility in Water:SOLUBLE
Appearance and Odor:CLEAR, COLORLESS LIQ IN A 1.5 ML GLASS SYRINGE & IN
    A 4 ML GLASS SCREW (SUP DAT
*  Stability and Reactivity Data  *
Stability Indicator/Materials to Avoid:YES
NO INFORMATION FOUND.
Stability Condition to Avoid:NONE SPECIFIED BY MANUFACTURER.
Hazardous Decomposition Products:MAY EMIT RADIOACTIVE FUMES CONTAINING
*  Disposal Considerations  *
Waste Disposal Methods:ENSURE COMPLIANCE W/LOCAL, STATE & FEDERAL
    REGULATIONS.
